Using dynamic treatment regimes to understand erythropoietin-stimulating agent hyporesponsiveness.

Saved in:
Bibliographic Details
Title: Using dynamic treatment regimes to understand erythropoietin-stimulating agent hyporesponsiveness.
Authors: Pollack AH; Division of Nephrology, Seattle Children's Hospital, Seattle, WA, USA. ari.pollack@seattlechildrens.org.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA. ari.pollack@seattlechildrens.org., Oron AP; Section of Epidemiology, Institute for Disease Modeling, Bellevue, WA, USA., Flynn JT; Division of Nephrology, Seattle Children's Hospital, Seattle, WA, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA., Munshi R; Division of Nephrology, Seattle Children's Hospital, Seattle, WA, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2018 Aug; Vol. 33 (8), pp. 1411-1417. Date of Electronic Publication: 2018 Apr 04.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-198X (Electronic) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-198X
DOI:10.1007/s00467-018-3948-9